1. Plasma Cytokines and Future Risk of Non-Hodgkin Lymphoma (NHL): A Case-Control Study Nested in the Italian European Prospective Investigation into Cancer and Nutrition
- Author
-
Saberi Hosnijeh, F., Krop, E.J.M., Scoccianti, C., Krogh, V., Palli, D., Panico, S., Tumino, R., Sacredote, C., Nawroly, N., Portengen, L., Linseisen, J., Vineis, P., Vermeulen, R., Risk Assessment of Toxic and Immunomodulatory Agents, Dep IRAS, Risk Assessment of Toxic and Immunomodulatory Agents, Dep IRAS, Saberi Hosnijeh, F, Krop, Ej, Scoccianti, C, Krogh, V, Palli, D, Panico, Salvatore, Tumino, R, Sacredote, C, Nawroly, N, Portengen, L, Linseisen, J, Vineis, P, and Vermeulen, R.
- Subjects
Adult ,Male ,Epidemiology ,Population ,Down-Regulation ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,immune system diseases ,Immunopathology ,hemic and lymphatic diseases ,Medicine ,Humans ,Prospective Studies ,Risk factor ,education ,Prospective cohort study ,030304 developmental biology ,Aged ,2. Zero hunger ,0303 health sciences ,education.field_of_study ,Biological markers ,business.industry ,Lymphoma, Non-Hodgkin ,Case-control study ,Middle Aged ,medicine.disease ,Intercellular adhesion molecule ,3. Good health ,European Prospective Investigation into Cancer and Nutrition ,Non-Hodgkin's lymphoma ,Oncology ,Risk factors ,Italy ,030220 oncology & carcinogenesis ,Case-Control Studies ,Immunology ,Cytokines ,Female ,business ,Biomarkers - Abstract
Recently, biological markers related to the immune system such as cytokines have been studied to further understand the etiology of non-Hodgkin Lymphoma (NHL). However, to date, there are no studies that have studied cytokine levels prospectively in relation to NHL risk in the general population. Using bead-based immunoassays, plasma levels of 11 cytokines, 4 chemokines, and 1 adhesion molecules were measured in prediagnostic blood samples of 86 NHL cases and 86 matched controls (average time between blood collection and diagnosis, 4.5 y). Conditional logistic regression adjusted for body mass index and alcohol consumption was used to analyze the association between individual plasma cytokine levels and the risk of developing NHL. In multivariate models, excluding cases diagnosed within 2 years after inclusion, we observed a significant association for interleukin 2 (IL2; P trend = 0.004), interferon (IFN)-gamma (P trend = 0.05), and intercellular adhesion molecule (ICAM) (P trend = 0.04). Subanalyses of B-cell NHL patients showed a significant association with IL2 (P trend = 0.003), tumor necrosis factor-alpha (TNF-alpha; P trend = 0.03), and ICAM (P trend = 0.04) and a borderline association with IL5 (P trend = 0.07) and IFN-gamma (P trend = 0.08). The results of this study suggest, in a prospective setting, a possible association between plasma levels of IL2, ICAM, IFN-gamma, and TNF-alpha with NHL risk and provide some evidence that risk of NHL might be related to a downregulation of T helper 1 cytokines. Identification of subtle changes in immune response regulation quantified by plasma cytokine levels possibly provides new insights in the etiology of NHL. The EPIC study was funded by “Europe Against Cancer” Programme of the European Commission (SANCO), Italian Association for Research on Cancer, Italian National Research Council, and Compagnia di San Paolo. This work was supported by the Environmental Cancer Risk, Nutrition and Individual Susceptibility Network of Excellence, operating within the European Union 6th Framework Program, Priority 5: Food Quality and Safety (FOOD-CT-2005-513943). F. Saberi Hosnijeh acknowledges the Iranian Ministry of Health and Medical Education for support of a Ph.D. program at Utrecht University.
- Published
- 2010
- Full Text
- View/download PDF